LakeShore Biopharma Files 6-K with Press Release
Ticker: LSBWF · Form: 6-K · Filed: Jul 8, 2025 · CIK: 1946399
| Field | Detail |
|---|---|
| Company | Lakeshore Biopharma CO., LTD. (LSBWF) |
| Form Type | 6-K |
| Filed Date | Jul 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, press-release, corporate-update
TL;DR
LakeShore Biopharma dropped a 6-K with a press release on July 8th.
AI Summary
On July 8, 2025, LakeShore Biopharma Co., Ltd. (formerly YS Biopharma Co., Ltd. and YishengBio Co., Ltd.) issued a press release attached to its Form 6-K filing. The company is incorporated in E9 and its principal executive offices are located in Beijing, China.
Why It Matters
This filing indicates ongoing corporate activity and communication from LakeShore Biopharma, potentially impacting investors' understanding of the company's status and future plans.
Risk Assessment
Risk Level: low — The filing is a routine report of a press release and does not contain significant new financial or operational information that would inherently increase risk.
Key Players & Entities
- LakeShore Biopharma Co., Ltd. (company) — Registrant
- YS Biopharma Co., Ltd. (company) — Former company name
- YishengBio Co., Ltd (company) — Former company name
- July 8, 2025 (date) — Date of press release issuance
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report a press release issued by LakeShore Biopharma Co., Ltd. on July 8, 2025.
What were LakeShore Biopharma's previous names?
LakeShore Biopharma Co., Ltd. was formerly known as YS Biopharma Co., Ltd. and YishengBio Co., Ltd.
When did the company change its name from YS Biopharma Co., Ltd.?
The company changed its name from YS Biopharma Co., Ltd. on March 10, 2023.
Where are LakeShore Biopharma's principal executive offices located?
LakeShore Biopharma's principal executive offices are located at Building 2, 38 Yongda Road, Daxing Biomedical Industry Park, Daxing District, Beijing, People's Republic of China.
Does LakeShore Biopharma file annual reports under Form 20-F or Form 40-F?
LakeShore Biopharma indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 8, 2025 regarding LakeShore Biopharma Co., Ltd. (LSBWF).